Clinical Trial - Radiolabeled Glass Beads in Treating Patients - Liver Cancer

Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. Using radiolabeled glass beads to kill tumor cells may be effective treatment for liver cancer that cannot be removed by surgery.


Study Type: Observational
Estimated Enrollment: 500 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Humanitarian Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Hepatocellular Carcinoma
Actual Study Start Date: December 2004
Estimated Primary Completion Date: January 2020
Estimated Study Completion Date: January 2021



Contact: Clinical Trials Office – Robert H. Lurie Comprehensive Cancer    312-695-1301 Identifier: NCT00530010


For enrollment please visit

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.